πŸ‡ΊπŸ‡Έ FDA
Patent

US 7700134

Prevention of cisplatin induced deafness

granted A61KA61K31/17A61K33/243

Quick answer

US patent 7700134 (Prevention of cisplatin induced deafness) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/17, A61K33/243, A61P, A61P27/16